Analytical Data
-
基因名
FAM80B
- Application
-
别名
Beta citrylglutamate synthase B; Beta-citryl-glutamate synthase B; FAM80B; Family with sequence similarity 80 member B; KIAA1238; N acetylaspartyl glutamate synthetase B; N-acetyl-aspartyl-glutamate synthetase B; NAAG synthetase B; NAAGS; NAAGS I
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9ULI2
-
表达区间
1-307aa
-
氨基酸序列
MCSSVAAKLWFLTDRRIREDYPQKEILRALKAKCCEEELDFRAVVMDEVVLTIEQGNLGLRINGELITAYPQVVVVRVPTPWVQSDSDITVLRHLEKMGCRLMNRPQAILNCVNKFWTFQELAGHGVPLPDTFSYGGHENFAKMIDEAEVLEFPMVVKNTRGHRGKAVFLARDKHHLADLSHLIRHEAPYLFQKYVKESHGRDVRVIVVGGRVVGTMLRCSTDGRMQSNCSLGGVGMMCSLSEQGKQLAIQVSNILGMDVCGIDLLMKDDGSFCVCEANANPFQEPKKQIQTNKKIPREKTFLLPPS
-
分子量
61 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM80B, a member of the FAM80 family, has garnered significant attention in recent years due to its potential roles in cellular processes and disease mechanisms. This protein is involved in regulating various cellular functions, including cell proliferation, apoptosis, and differentiation. Research has indicated that alterations in FAM80B expression may be implicated in various cancers, making it a target for therapeutic intervention. The exploration of FAM80B as a recombinant protein offers insights into its structural and functional characteristics, facilitating the understanding of its biological roles. Recombinant protein studies enable researchers to investigate the molecular mechanisms by which FAM80B exerts its effects in cellular contexts, paving the way for novel approaches in cancer treatment and other disease models. Additionally, the production of FAM80B as a recombinant protein provides a valuable tool for high-throughput screening and potential drug discovery efforts. Understanding the interactions and pathways associated with FAM80B could uncover new therapeutic targets and lead to innovative strategies for managing diseases linked to its dysregulation. As research progresses, the characterization of FAM80B and its implications in health and disease remain pivotal for advancing our knowledge in molecular biology and cancer research.
